Massachussetts

WESTFORD, Massachussetts, May 30, 2011 - Sonus Networks, Inc.

NATICK, Massachussetts, May 26, 2010 - Boston Scientific Corporation (NYSE: BSX) today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS(R) Element(TM) Everolimus-Eluting Coronary Stent System to the XIENCE PRIME(TM) Everolimus-Eluting Coronary Stent System.